Clinical Trial

The Prevalence of Hyper-Lp(a)-Emia in the PMMHRI-Lp(a) Registry

Recruiting
View on ClinicalTrials.gov →
Summary
The PMMHRI-Lp(a)-Registry is a non-interventional, single-center registry conducted in the Polish Mother's Memorial Hospital Research Institute (PMMHRI). The PMMHRI-Lp(a)-Registry was established in January 2022. Since then, all consecutive patients of the Department of Cardiology and Adult Congenital Heart Diseases, Department of Endocrinology, and outpatient cardiology and endocrinology clinics with the measured Lp(a) concentration have been included.
Trial Details
NCT Number NCT06610669
Lead Sponsor Polish Mother Memorial Hospital Research Institute
Conditions Lipoprotein(a), Hyper-Lp(a)-Emia
Enrollment 2,000 participants
Start Date 2022-01-01
Primary Completion 2028-01 (estimated)
Study Completion 2028-06 (estimated)
Updated on ClinicalTrials.gov 2024-09-24